EUCTR2019-000895-40-DKActive, not recruitingPhase 1
Beta-agonist Efficacy and Tolerability as Adjuvant therapy in Myasthenia Gravis - BETA-MG
Aarhus University Hospital0 sites30 target enrollmentStarted: February 26, 2019Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Generalized myasthenia gravis, stable dose of antimyasthenic medications, residual symptoms (MG-QOL15 > 10), age > 18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 15
Exclusion Criteria
- •Malignant disease, worsening of symptoms due to concomitant diseases/medications, pregnancy/breast feeding, ischemic heart disease/cardiac arrhytmia/uncontrolled hypertension/uncontrolled diabetes
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Association of efficacy of long acting beta 2-agonist (LABA) and single nucleotide polymorphisms (SNP) of beta 2-adrenergic receptors in elderly patients with COPDJPRN-UMIN000002629Tokyo Metropolitan Geriatric Hospital50
Unknown
Phase 2
Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia GravisMyasthenia GravisNCT03914638University of Aarhus30
Completed
Not Applicable
Efficacy and safety of long-acting beta-2 agonist and long-acting muscarinic antagonist combinations in patients with chronic obstructive pulmonary disease: meta-analysis of phase 3 randomized trialschronic obstructive pulmonary diseaseJPRN-UMIN000026496Showa University5,000
Active, not recruiting
Not Applicable
Will it be better to use Beta Blocker and Procoralan when suffering of chronical heart failure, in order to reduce heart frequence at rest?Patients with chronic heart failure and resting heart rate of = 75 bmpEUCTR2014-000269-27-DEGerman Foundation for Chronically Ill
Not yet recruiting
Phase 2
A randomized controlled trial for beta agonist on ulolithiasis patients associated with overactive bladder.urolithiasisJPRN-UMIN000010553Department of Urology, Isehara Kyodo Hospital100